Analysis of Inhaled Corticoid Prescriptions in General Medicine
NCT ID: NCT03179826
Last Updated: 2019-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2017-07-13
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The prescription of inhaled corticosteroids, often initiated during a general medicine consultation, is not simple. The aim of this study is to analyze the relevance of the prescription of inhaled corticosteroids in primary care and to identify the criteria necessary for the prescription of inhaled corticosteroids available in general practice.
The main objective of our study is to evaluate the rate of consultations where all the elements required for guiding the prescription of an inhaled corticoid are available.
The secondary objectives are:
* Identify other factors associated with decision-making
* Identify the causes of inhaled corticosteroid stopping (de-prescription)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Inhaled Corticosteroids on Sputum Bacterial Load in COPD
NCT01213693
Symbicort in Chronic Obstruktive Pulmonary Disease
NCT00612976
Efficacy of Corticosteroids to Treat Outpatients With Acute Exacerbations of COPD
NCT02330952
Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State
NCT02103374
A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium
NCT01691482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study population
Adults consulting with one of the participating general practitioners and requiring long term inhaled corticoids and monitoring.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed and not opposed to participate in this research
Exclusion Criteria
* Adults under any kind of guardianship -
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud Bourdin, MD, PhD
Role: STUDY_DIRECTOR
Montpellier University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet de médecine générale
Clapiers, , France
Cabinet de médecine générale
Saint-Martin-de-Londres, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A01230-53
Identifier Type: OTHER
Identifier Source: secondary_id
RECHMPL17-0152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.